General Information

CONFERENCE INFORMATION

Adherence 2021 will take place June 13-15, 2021, at the Loews Portofino Bay in Orlando, FL, USA. Sponsored by the International Association of Providers of AIDS Care (IAPAC), this annual series of conferences features the presentation and discussion of HIV treatment and biomedical prevention adherence research, and current behavioral and clinical perspectives in practicum, within the context of optimizing the continuum of HIV care and prevention. The 2021 conference’s Co-Chairs are Jane M. Simoni, Ph.D (University of Washington, Seattle, WA, USA) and Till Bärnighausen, MD, ScD, MSc (University of Heidelberg, Germany). Adherence 2021 will feature a five-track program:

  • Treatment Adherence
  • Community Engagement
  • Biomedical Prevention
  • Continuum of Care
  • Implementation Science

CONTINUING EDUCATION

LEARNING OBJECTIVES
Upon successful completion of this activity, learners will be able to:

  • Employ interventions to enhance linkage to and engagement and retention in HIV care
  • Apply strategies to optimize antiretroviral therapy and pre-exposure prophylaxis adherence
  • Develop strategies to manage syndemic conditions and disorders associated with HIV
  • Recognize science-to-practice gaps in implementing innovative HIV policies and programs
  • Deploy measures to mitigate HIV service disruption within the context of public health crises

TARGET AUDIENCE
The target audience for Adherence 2021 conference includes physicians, nurses and nurse-practitioners, pharmacists, psychologists, behavioral scientists, social scientists, public health specialists, epidemiologists, social workers, case managers, peer educators and navigators, and community health workers working in the field of HIV medicine. The conference may also be of interest to individuals who wish to implement and advocate for effective, evidence informed HIV policies and interventions in their respective communities and countries.

ACCREDITATION
Adherence 2021
is currently pending application of accreditation for physicians, nurses/nurse practitioners, pharmacists, psychologists, and other credentials.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.


EXHIBITOR AND SPONSORSHIP INFORMATION

Adherence 2021 provides the opportunity to interact with more than 500 delegates from a variety of practice settings and experiences, including physicians, nurses, pharmacists, psychologists, social workers, community health workers, and patient advocates. There are a limited number of virtual exhibitor spaces for this conference. Please contact IAPAC’s Senior Director of Education, Jonathon Hess, at jhess@iapac.org with any exhibitor-related queries.


REGISTRATION

Registration fees are listed in US dollars and apply to payments received prior to the deadlines below.

Registration fees include:

• Participation in Satellite Symposia
• Conference materials (e.g., Program & Abstracts book)

Deadline February 12, 2021 March 19, 2021 April 30, 2021 N/A
Registration Type Early-Bird Early Standard Late/Onsite
Member (must be current) $275 $325 $375 $425
Non-Member $300 $350 $400 $450
Student or Retired $225 $250 $275 $300
One-Day Only $150 $175 $200 $250

 


KEY DATES

Registration

  • Early-Bird Registration Deadline – February 12, 2021
  • Early Registration Deadline – March 19, 2021
  • Standard Registration Deadline – April 30, 2021
  • Registration Cancellation Deadline (with $100 penalty) – May 14, 2021

Abstract Submission/Disposition

  • Abstract Submission Deadline – February 26, 2021
  • Abstract Disposition Announcements – March 31, 2021
  • Late-Breaker Abstract Submissions – April 5-9, 2021
  • Late-Breaker Abstract Disposition Announcements – April 30, 2021
  • Early Registration Rate (for presenting authors only) – May 7, 2021
  • Deadline to Withdraw Abstract/Change Presenting Author – May 14, 2021

Hotel Accommodations

  • Discounted Room Block Reservation Deadline – May 19, 2021

COMMERCIAL SPONSORS

Adherence 2021 is made possible through an educational grant from Gilead Sciences. Other educational grants and corporate sponsorships will be announced as they are received.

Program

Adherence 2021 will consist of 2 and 1/2 days of plenary sessions, panels, oral abstract presentations, and e-poster abstracts. This will be preceded by 1/2 day of pre-conference sessions.

The conference will focus on state-of-the-science evidence, best practices, and the practical, real-world implementation of behavioral, clinical, structural, and other interventions to maximize the therapeutic and preventative effects of antiretroviral agents. The conference will also provide a forum for discussion and presentation of implementation science focused on closing evidence-to-practice gaps across the HIV prevention and care continua, as well as community engagement in planning, implementing, and monitoring HIV responses in their communities.

THEME AND FORMAT

The Adherence 2021 theme is New Targets, New Opportunities. The conference will feature a keynote address, memorial lecture, and memorial colloquium, as well as plenary addresses, panel discussions, oral abstract sessions, and an e-poster session.

LEARNING OBJECTIVES

At the conclusion of this educational activity, learners should be able to:

    • Employ interventions to enhance linkage to and engagement and retention in HIV care
    • Apply interventions to enhance and support optimal patient adherence to ART and PrEP
    • Integrate into clinical practice strategies to manage syndemic conditions associated with HIV
    • Describe the framework for designing implementation strategies for successful HIV responses
    • Promote engagement by communities in planning, implementing, and monitoring HIV responses

The Adherence 2021 conference program will be announced in January 2021.

Register

Venue and Accommodations

Orlando Luxury Resorts | Loews Portofino Bay at Universal Studios

The venue for Adherence 2021 is the Loews Portofino Bay Hotel (5601 Universal Blvd, Orlando, FL 32819).

IAPAC has secured a discounted room rate of $219/night plus sales/occupancy tax for the nights of June 8th – 20th, 2021.

Government per diem rooms may be reserved at a rate of $129/night plus sales/occupancy tax at Universal’s Cabana Bay Beach Resort. Government ID will be required at check-in to secure the per diem rate. Complimentary shuttle service will be provided to the Loew’s Portofino Bay Hotel.

The reservation cutoff date is May 19th, 2021 at 5:00pm ET.

Click here to book your discounted room today.

Submit an Abstract

Adherence 2021 will feature oral abstract and e-poster sessions. The abstract submission portal, which will communicate guidance related to abstract categories and submissions will be available Wednesday, December 23, 2020. The portal will be open for submissions through the two timeframes specified below for standard abstract and late-breaker abstract submission.

 

KEY DATES


Following are key dates relevant to abstract submissions:

  • Abstract Submission Deadline – February 26, 2021
  • Abstract Disposition Announcements – March 31, 2021
  • Late-Breaker Abstract Submissions – April 5-9, 2021
  • Late-Breaker Abstract Disposition Announcements – April 30, 2021
  • Early Registration Rate (for presenting authors only) – May 7, 2021
  • Deadline to Withdraw Abstract/Change Presenting Author – May 14, 2021

 

CALL FOR ABSTRACTS


Abstract submissions are encouraged in a wide variety of specific domains, including:

  • Antiretroviral therapy medication and medication adherence
  • Linkage, retention, and re-engagement in HIV care
  • Adherence and engagement in biomedical HIV prevention strategies
  • Implementation science strategies
  • Community engagement in planning, implementing, and monitoring HIV responses

Within these areas we encourage coverage of:

  • Advances in basic science
  • Innovative monitoring strategies
  • Longitudinal or observational data
  • Innovations in modeling and biopsychosocial theory
  • Intervention development, implementation, and/or outcomes
  • Dissemination/implementation of evidence-based approaches
  • Operations research, demonstration projects, and practice-based approaches
  • Health care policy and financing at local, state, and national levels
  • Resource, structural, and service delivery issues and innovations
  • Implementation science design, evidence, and real-world applicability
  • Continuity of care in the context of COVID-19
  • Mitigation of HIV service disruption within the context of public health crises

Particularly as applied to key and disproportionately affected populations and settings:

  • Treatment naïve, treatment experienced
  • Individuals living with mental and/or physical health challenges
  • Concomitant diseases (e.g., HBV, HCV, TB)
  • Comorbid conditions (e.g., diabetes, hypertension)
  • Syndemic conditions (e.g., mental health, substance use)
  • Resource-constrained settings and geographies
  • Key and vulnerable populations:
    • Men who have sex with men (MSM)
    • Transgender individuals
    • Women in high HIV incidence areas
    • Female and male sex workers
    • Pregnant women
    • Children and adolescents
    • Substance users
    • Incarcerated or recently released individuals
    •  Homeless and/or marginally housed individuals

ABSTRACT SUBMISSION


Abstracts must be submitted online by 5 pm ET, February 26, 2021. Submitted abstracts will be considered for oral or e-poster presentation. Submitted abstracts should report information not previously published, or intended to be published, prior to May 14, 2021.

It is the responsibility of the presenting author to ensure accuracy of content, spelling, and presentation. Abstracts will be published as submitted, subject to reformatting that may be required by IAPAC.

ABSTRACT FORMAT


Abstract contents will be either research-based data using established scientific methods or demonstrate experience and information from individuals or institutions working in the field. Please follow one of two structured formats (A or B), indicating in bold the four parts of your abstract:

Format A: Data-Driven Abstracts

  1. Background: a concise statement of the issues evaluated
  2. Methods: the investigational model used
  3. Results: specific findings
  4. Conclusions: summary of findings, supported by results

Format B: Program Descriptions and Case Studies

  1. Introduction: a concise statement of the issues addressed
  2. Description: a description of the project, case study, experience, or intervention
  3. Lessons Learned: project results, implementation issues, and/or case study solutions
  4. Recommendations: further recommendations or next steps

GENERAL GUIDELINES


Following are some general guidelines for individuals interested in submitting an abstract(s):

  • The abstract must NOT contain more than 300 words.
  • Acceptable abstracts shall contain a concise statement of the research, define the precise subject of the presentation, and be related to the main theme or a sub-theme of the conference.
  • Literature references and acknowledgements should not form any part of the abstract’s content.
  • Figures and tables are acceptable, subject to high definition/quality guidance to be provided.
  • The author is responsible for grammatical and factual details, and may edit an abstract after it has been submitted up to May 14, 2021.
  • All abstracts must be submitted in English (without exception).
  • Sub-specialty jargon should be avoided, reflecting the interdisciplinary nature of the conference.
  • Define all abbreviations and concepts in your abstract at first use.
  • For therapeutic agents, only generic names may be used (trade names are not permitted).

ABSTRACT SUBMISSION AND ACCEPTANCE


All abstracts must be submitted online no later than 5:00 pm ET, February 26, 2021. Submissions will be acknowledged upon successful submission via the site. Faxed or mailed abstracts will not be considered.

Please record your abstract number. The number assigned to your abstract when it is submitted online will be the abstract number referenced throughout the conference, including in the Program and Abstracts book, during the Oral Abstract sessions, and during the e-Poster Session. A notice of acceptance or rejection will be sent via e-mail no later than March 31, 2021. The disposition of each abstract will be sent via e-mail only to the submitting author identified on the submission form for that abstract. That contact will be responsible for sharing the disposition with all other authors of the abstract (including the presenting author).

Accepted abstracts will be in one of two categories:

1.      Oral Abstract presentation
2.      e-Poster Abstract presentation

Presenting authors agree to register for and attend the conference as scheduled in either Oral Abstract sessions or the e-Poster Session. Oral abstract and e-poster presenters are responsible for their own travel and accommodation expenses, as well as the applicable registration fees.

Note that only the abstracts of paid conference registrants will be included in the final Program and Abstracts Book. Accepted abstracts will be published in the conference proceedings. Abstracts are considered official communication to IAPAC. Submission of an abstract implies permission to publish abstracts (including in the Journal of the International Association of Providers of AIDS Care [JIAPAC]) and online posting, if accepted. E-posters files must be transferred to IAPAC by May 14, 2021. any electronic presentation and handouts will be transferred to IAPAC.

To reiterate, all abstract submissions must be received online by 5:00 pm ET, February 26, 2021. It is strongly recommended that you do not wait until the last minute to submit your abstract(s). You may review/edit submissions from now until 5:00 pm ET, May 14, 2021. Abstracts may be withdrawn or the presenter may be changed until May 14, 2021.

Login or Register to submit an abstract

Family/Leisure

Adherence 2021 will take place at the Loews Portofino Bay Hotel in Orlando, FL, USA, which is also the conference’s official hotel. Conference delegates may take advantage of a variety of family-friendly and leisure activities in close proximity to the Loews Portofino Bay Hotel, including restaurants at Universal CityWalk, entertainment at Universal Studios Florida and Universal’s Islands of Adventure, and Walt Disney World.

Delegates staying at the Loews Portofino Bay Hotel will receive the following benefits:

  • Complimentary water taxi and shuttle bus service to/from Universal CityWalk
    • Access point for Universal Studios Florida and Universal’s Islands of Adventure
  • Complimentary Universal Express Unlimited ride access to skip the regular lines in Universal Studios Florida and Universal’s Islands of Adventure
  • Half-price admission pricing to Universal Studios Florida and Universal’s Islands of Adventure after 4:00 pm daily


					

Our Conferences

Virtual

October 2020 - March 2021

Learn More

Orlando

June 13 - 15, 2021

Register

Amsterdam

October 16 - 17, 2021

View Archives

Lisbon

October 20 - 22, 2021

Register

Virtual

May 6, 2020

View Archives

Virtual

June 30 - July 1, 2020

View Archives